RA Capital Management »

Hemab Therapeutics Holdings shares owned by RA Capital Management

Quarter-by-quarter ownership of Hemab Therapeutics Holdings shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Hemab Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Hemab Therapeutics Holdings held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hemab Therapeutics Holdings by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $287M 7.8M 36.73

More positions owned by RA Capital Management

Ascendis Pharma A/s Common Stock (ASND)
Parabilis Medicines Common Stock
Rhythm Pharmaceuticals Common Stock (RYTM)
Vaxcyte Common Stock (PCVX)
Sionna Therapeutics Common Stock (SION)
Tyra Biosciences Common Stock (TYRA)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Hemab Therapeutics Holdings Common Stock
Septerna Common Stock (SEPN)
Bicara Therapeutics Common Stock (BCAX)
Mineralys Therapeutics Common Stock (MLYS)
Gh Research Common Stock (GHRS)
Disc Medicine Common Stock (IRON)
Spyglass Pharma Common Stock (SGP)

View all positions for RA Capital Management

Top funds holding Hemab Therapeutics Holdings

RA Capital Management
Novo A/S
Jpmorgan Chase & Co
Vanguard Capital Management
Citadel Advisors
Braidwell
Marshall Wace
Affinity Asset Advisors
Vanguard Fiduciary Trust
Burkehill Global Management
Standard Life Aberdeen
TD Asset Management
GSA Capital Partners
Schonfeld Strategic Advisors
Vanguard Portfolio Management

View all funds holding Hemab Therapeutics Holdings